ABT
Abbott LaboratoriesCompany with tickers: ABT
CIK
1800
CUSIP
002824100
Shares Outstanding
1,741,813,154
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $11,164,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $767,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Operating Income | $1,345,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Net Income | $1,077,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| EPS (Basic) | $0.62 | USD/shares | 2026-03-31 | 10-Q | 2026-04-29 |
| EPS (Diluted) | $0.61 | USD/shares | 2026-03-31 | 10-Q | 2026-04-29 |